Michael R Wood Selected Research

Michael R Wood Research Topics

8	Schizophrenia (Dementia Praecox) 02/2017 - 05/2010
5	Inflammation (Inflammations) 01/2022 - 05/2003
4	Chronic Pain 01/2022 - 05/2003
4	Alzheimer Disease (Alzheimer's Disease) 08/2015 - 01/2012
2	Pain (Aches) 01/2022 - 01/2007
1	Rare Diseases (Rare Disease) 01/2022
1	Pericarditis 01/2022
1	Infections 01/2021
1	COVID-19 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 06/2014
1	Nervous System Diseases (Neurological Disorders) 01/2012
1	Neurobehavioral Manifestations 05/2010
1	Hyperalgesia 05/2003

7	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2015 - 05/2010
2	Cholinergic Agents (Cholinergics)IBA 12/2013 - 05/2010
2	Muscarinic AgonistsIBA 01/2012 - 05/2010
2	BradykininIBA 01/2008 - 05/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	VU0467485IBA 02/2017
1	VU0476406IBA 01/2017
1	5- amino- 3,4- dimethyl- N- (4- ((trifluoromethyl)sulfonyl)benzyl)thieno(2,3- c)pyridazine- 6- carboxamideIBA 03/2016
1	Hypnotics and Sedatives (Sedatives)IBA 03/2016
1	N-Methylaspartate (NMDA)IBA 03/2016
1	Dizocilpine Maleate (Dizocilpine)IBA 03/2016
1	Glutamate Receptors (Glutamate Receptor)IBA 03/2016
1	Clozapine (Clozaril)FDA LinkGeneric 03/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 12/2013
1	benzocycloheptapyridineIBA 01/2013
1	ML253IBA 01/2013
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2012
1	Cholinergic Antagonists (Anticholinergics)IBA 05/2010
1	xanomelineIBA 05/2010
1	Bradykinin B1 Receptor AntagonistsIBA 01/2007
1	Bradykinin B1 ReceptorIBA 02/2006
1	Morphine (MS Contin)FDA LinkGeneric 05/2003

1	Biological Therapy 01/2021